
📢 🧬🚀 We’re proud to announce that Integra Therapeutics secures €10.7 million pre Series A investment round to advance development of our #FiCAT gene writing platform and preclinical validation of CAR-T therapies: integra-tx.com/integra-thera… #GeneTherapy #CellTherapy













